Induction of apoptosis in HL60 leukemic cells by anticancer drugs in combination with anti-fas monoclonal antibody

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 173-179

  Nakamura, Shinobu ^a   Takeshima, Minoru ^a   Nakamura, Yoshihisa ^a   Ohtake, Shigeki ^a   Matsuda, Tamotsu ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

Anti Fas monoclonal antibody; Anticancer drugs; Apoptosis; Cell death; Fas antigen; HL60 cells

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; DNA FRAGMENT; DOXORUBICIN; FAS ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

AGAR GEL ELECTROPHORESIS; APOPTOSIS; ARTICLE; CELL KILLING; CELL STRAIN HL 60; CELL STRUCTURE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LEUKEMIA CELL; PRIORITY JOURNAL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; ANTINEOPLASTIC AGENTS; APOPTOSIS; CYTARABINE; DNA; DOXORUBICIN; HL-60 CELLS; HUMANS; IMMUNOGLOBULIN M;

EID: 0031043867     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kerr JFR, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
2. Kaufmann SH: Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note. Cancer Res 49: 5870-5878, 1989.
3. Gunji H, Kharbanda S and Kufe D: Induction of internucleosomal DNA fragmentation in human myeloid leukemia cells by 1-β-D-arabinofuranosylcytosine. Cancer Res 57: 741-743, 1991.
4. Tritton TR: Cell death in cancer chemotherapy: the case of adriamycin. In: Apoptosis. The molecular basis of cell death (Tomei LD and Cope FO, eds). New York, Cold Spring Harbor Laboratory Press. 1991, pp121-137.
5. Yonehara S, Ishii A and Yonehara M: A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 169: 1747-1756, 1989.
6. Trauth BC, Klas C, Peters AMJ, Matzku S, Möller P, Falk W, Debatin K-M and Krammer PH: Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305, 1989.
7. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S and Sameshima M: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991.
8. Bhalla K, Tang C, Ibrado AM, Grant S, Tourkina E, Holladay C, Hughes M, Mahoney ME and Huang Y: Granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) enhances high-dose Ara-C-induced programmed cell death or apoptosis in human myeloid leukemia cells. Blood 80: 2883-2890, 1992.
9. Lotem J and Sachs L: Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor β1 and cancer chemotherapy compounds in myeloid leukemic cells. Blood 80: 1750-1757, 1992.
10. 2 phase and cell death induced by cisplatin. J Natl Cancer Inst 82: 749-755, 1990.
11. Walker PR, Smith C, Youdale T, Leblanc J, Whitfield JF and Sikorska M: Topoisomerase II-reactive chemotherapeutic drugs induce apoptosis in thymocytes. Cancer Res 51: 1078-1085, 1991.
12. Hotz MA, Traganos F and Darzynkiewicz Z: Changes in nuclear chromatin related to apoptosis or necrosis induced by the DNA topoisomerase II inhibitor fostriecin in MOLT-4 and HL-60 cells are revealed by altered DNA sensitivity to denaturation. Exp Cell Res 201: 184-191, 1992.
13. Kizaki H, Ohnishi Y, Azuma Y, Mizuno Y and Ohsaka F: 1-β-D-arabinosylcytosine and 5-azacytidine induce internucleosomal DNA fragmentation and cell death in thymocytes. Immunopharmacol 24: 219-227, 1992.
14. Morimoto H, Yonehara S and Bonavida B: Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins. Cancer Res 53: 2591-2596, 1993.
15. Wyllie AH: Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284: 555-550, 1980.
16. Chaires JB, Fox KR, Herrera JE, Britt M and Waring MJ: Site and sequence specificity of the daunomycin-DNA interaction. Biochemistry 26: 8227-8236, 1987.
17. Tewey KM, Rowe TC, Yang L, Halligan BD and Liu LF: Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466-468, 1984.
18. Posada J, Vichi P and Tritton TR: Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res 49: 6634-6639, 1989.
19. Major P, Egan EM, Beardsley G, Minden M and Kufe DW: Lethality of human myeloblasts correlates with the incorporation of ara-C into DNA, Proc Natl Acad Sci USA 78: 3235-3239, 1981.
20. Nishizuka Y: The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698, 1984.
21. Tritton TR and Hickman JA: How to kill cancer cells: membranes and cell signaling as targets in cancer chemotherapy. Cancer Cells 2: 95-105, 1990.